CAS 170729-80-3
:Aprepitant
Descrição:
Aprepitant é um antagonista seletivo do receptor de neuroquinina-1 (NK1), utilizado principalmente na prevenção de náuseas e vômitos associados à quimioterapia e à cirurgia. É classificado como uma pequena molécula e frequentemente administrado por via oral. Aprepitant exibe alta afinidade pelo receptor NK1, que desempenha um papel crucial na resposta emética mediada pela substância P, um neuropeptídeo envolvido na percepção da dor e na inflamação. A substância é caracterizada por sua relativamente baixa solubilidade em água, o que influencia sua formulação e biodisponibilidade. Aprepitant é tipicamente utilizado em combinação com outros agentes antieméticos para aumentar a eficácia terapêutica. Sua farmacocinética envolve extenso metabolismo no fígado, principalmente através do sistema do citocromo P450, levando a potenciais interações medicamentosas. Efeitos colaterais comuns podem incluir fadiga, tontura e distúrbios gastrointestinais. No geral, Aprepitant representa um avanço significativo no manejo de náuseas e vômitos induzidos por quimioterapia, melhorando a qualidade de vida dos pacientes em tratamento contra o câncer.
Fórmula:C23H21F7N4O3
InChI:InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1
Chave InChI:InChIKey=ATALOFNDEOCMKK-OITMNORJSA-N
SMILES:C(N1[C@H]([C@@H](O[C@H](C)C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)OCC1)C3=CC=C(F)C=C3)C4=NNC(=O)N4
Sinónimos:- 3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
- 3H-1,2,4-Triazol-3-one, 5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, [2R-[2α(R*),3α]]-
- 5-[2(R)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-ylmethyl]-3,4-dihydro-2H-1,2,4-triazol-3-one
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one, Emend
- 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one
- Emend
- L 754030
- Mk 869
- Mk-0869
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
17 produtos.
Aprepitant
CAS:Fórmula:C23H21F7N4O3Pureza:>98.0%(HPLC)Cor e Forma:White to Almost white powder to crystalPeso molecular:534.43Aprepitant
CAS:AprepitantFórmula:C23H21F7N4O3Pureza:99.9%Cor e Forma:White. To. BeigePeso molecular:534.15019Aprepitant
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C23H21F7N4O3Cor e Forma:White Off-White PowderPeso molecular:534.150195-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,3-dihydro-1H-1,2,4-triazol-3-one
CAS:Fórmula:C23H21F7N4O3Pureza:98%Cor e Forma:SolidPeso molecular:534.4267Ref: IN-DA0034H4
1g68,00€5g137,00€1kgA consultar25g308,00€5mg26,00€250gA consultar25mg30,00€500gA consultar50mg31,00€250mg31,00€500mg50,00€Aprepitant
CAS:Fórmula:C23H21F7N4O3Pureza:(HPLC) ≥ 98.0%Cor e Forma:White to off-white powderPeso molecular:534.43Aprepitant Impurity 31
CAS:Fórmula:C27H24F7NO2Cor e Forma:White To Off-White SolidPeso molecular:527.49Aprepitant
CAS:<p>Aprepitant (Aprepitant`) is a Substance P/Neurokinin-1 Receptor Antagonist.</p>Fórmula:C23H21F7N4O3Pureza:98% - 99.68%Cor e Forma:Off-White To Light Yellow Cyrstalline SolidPeso molecular:534.43Aprepitant
CAS:Produto Controlado<p>Applications Aprepitant is a neurokinin-1 antagonist and an antiemetic agent (1). It is used to prevent chemotherapy-induced nausea and vomiting (CINV) in colorectal cancer patients (2) Aprepitant has also been shown to induce apoptotic cell death and G1 arrest through Akt/p53 axis in pre-B acute lymphoblastic leukemia cells (3).<br>References (1) Takemoto, H., et al.: nt J Clin Oncol (2016) (2) Bayati, S., et al.: Eur J Pharmacol. 791, 274 (2016) (3) Navari, R.M.: Expert Rev Anticancer Ther. 4, 715 (2004)<br></p>Fórmula:C23H21F7N4O3Cor e Forma:Off-WhitePeso molecular:534.43Aprepitant
CAS:<p>Aprepitant is a neurokinin-1 receptor antagonist. It is an antiemetic which suppresses nausea and vomiting and has proven to be especially useful alongside cancer chemotherapy and as a tool in cancer-related studies. Aprepitant binds to the neurokinin-1 receptor in the brain, preventing it from binding to substance P. This prevents substance P from stimulating nerves in the vomiting center of the brain, reducing feelings of nausea and vomiting. Aprepitant has been shown to be effective against HIV infection, with no major side effects. The use of aprepitant for HIV therapy may be limited due to its ability to cause serious liver damage when taken with other drugs that are metabolized by cytochrome P450 enzymes.</p>Fórmula:C23H21F7N4O3Pureza:Min. 98%Cor e Forma:White Off-White PowderPeso molecular:534.43 g/molAprepitant - Bio-X ™
CAS:<p>Aprepitant is a neurokinin-1 receptor antagonist. It is an antiemetic which suppresses nausea and vomiting and has proven to be especially useful alongside cancer chemotherapy and as a tool in cancer-related studies. Aprepitant binds to the neurokinin-1 receptor in the brain, preventing it from binding to substance P. This prevents substance P from stimulating nerves in the vomiting center of the brain, reducing feelings of nausea and vomiting. Aprepitant has been shown to be effective against HIV infection, with no major side effects. The use of aprepitant for HIV therapy may be limited due to its ability to cause serious liver damage when taken with other drugs that are metabolized by cytochrome P450 enzymes.</p>Fórmula:C23H21F7N4O3Pureza:Min. 98 Area-%Peso molecular:534.43 g/mol













